403499-16-1

Basic information

• Product Name: (3S)-5-[(2-chloro-6-fluorobenzyl)oxy]-3-{[(2S)-2-{[(2,5-dimethoxyphenyl)acetyl]amino}-3-methylbutanoyl]amino}-4-oxo-pentanoic Acid
• Synonyms: (3S)-5-[(2-chloro-6-fluorobenzyl)oxy]-3-{[(2S)-2-{[(2,5-dimethoxyphenyl)acetyl]amino}-3-methylbutanoyl]amino}-4-oxo-pentanoic Acid
• CAS NO: 403499-16-1
• Molecular Weight: 567.011
• Mol File: 403499-16-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (3S)-5-[(2-chloro-6-fluorobenzyl)oxy]-3-{[(2S)-2-{[(2,5-dimethoxyphenyl)acetyl]amino}-3-methylbutanoyl]amino}-4-oxo-pentanoic Acid(CAS DataBase Reference)
• NIST Chemistry Reference: (3S)-5-[(2-chloro-6-fluorobenzyl)oxy]-3-{[(2S)-2-{[(2,5-dimethoxyphenyl)acetyl]amino}-3-methylbutanoyl]amino}-4-oxo-pentanoic Acid(403499-16-1)
• EPA Substance Registry System: (3S)-5-[(2-chloro-6-fluorobenzyl)oxy]-3-{[(2S)-2-{[(2,5-dimethoxyphenyl)acetyl]amino}-3-methylbutanoyl]amino}-4-oxo-pentanoic Acid(403499-16-1)

Safety Data

• Hazardous Substances Data: 403499-16-1(Hazardous Substances Data)

Upstream product

• 110-89-4 piperidine 
• 1758-25-4 (2,5-dimethoxyphenyl)acetic acid 
• 694-53-1 phenylsilane 

Relevant articles and documents

Gamma-ketoacid dipeptides as inhibitors of caspase-3

This invention encompasses the novel compounds of Formula I, which are useful in the treatment of caspase-3 mediated diseases. The invention also encompasses certain pharmaceutical compositions comprising compounds of Formula I as well as methods for treatment of caspase-3 mediated diseases.